Jonathan Hanna

Papers

Total Citations

H-Index

About

Jonathan Hanna is a leading voice in head and neck surgical oncology, with a focused expertise in transoral robotic surgery (TORS) for oropharyngeal and laryngeal cancers. His work has been instrumental in defining the real-world outcomes and safety of robotic techniques following their federal approval. In his landmark 2019 study published in a high-impact journal, Hanna conducted a national quality analysis of the National Cancer Database, revealing that the positive margin rate (PMR) for TORS in oropharynx cancer was 16.8%—a critical benchmark that has shaped surgical standards and quality improvement efforts. This paper, with 40 citations, remains a cornerstone reference for surgeons and institutions evaluating margin performance. Complementing this, his 2019 investigation into early T-stage laryngeal cancer provided the first nationwide comparison of TORS against open partial surgery and transoral laser microsurgery (TLM), demonstrating that robotic approaches offer comparable oncologic outcomes while expanding minimally invasive options. With 25 citations, this work has guided treatment de-escalation strategies. Hanna’s research is distinguished by its rigorous use of national datasets to answer pressing clinical questions, directly influencing surgical guidelines and patient counseling. His contributions have established him as a key figure in the evidence-based adoption of robotic surgery in head and neck oncology.